By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Protiva Biotherapeutics 

150 - 8900 Glenlyon Parkway

Burnaby  British Columbia  V5J 5J8  Canada
Phone: 604-419-3200 Fax: 604-419-3201



Company News
Tekmira Pharmaceuticals Corporation and Protiva Biotherapeutics Announce Completion of Business Combination 6/2/2008 12:58:50 PM
Alnylam Pharmaceuticals (ALNY) Announces Close of Investment and Expanded Agreement Related to the Tekmira Pharmaceuticals Corporation-Protiva Biotherapeutics Business Combination 6/2/2008 11:31:08 AM
Tekmira Pharmaceuticals Corporation and Protiva Biotherapeutics Announce Business Combination to Create New Company Focused on RNAi Delivery and Therapeutics 3/31/2008 6:59:46 AM
Tekmira Pharmaceuticals Corporation Provides Update on Ongoing Legal Dispute With Protiva Biotherapeutics 10/17/2007 9:02:48 AM
Merck & Co., Inc. (MRK) Licenses SNALP Technology From Protiva Biotherapeutics 10/17/2007 8:36:00 AM
Protiva Biotherapeutics Completes $3.5 Million Financing 7/5/2007 1:17:45 PM
Protiva Biotherapeutics Announces INEX Pharmaceuticals (IEX.TO) Bankruptcy Petition Withdrawn 4/24/2007 9:53:12 AM
Protiva Biotherapeutics: California Superior Court Grants Preliminary Injunction Prohibiting Sirna Therapeutics, Inc. (RNAI) From Using Protiva Technology 4/16/2007 10:25:06 AM
INEX Pharmaceuticals (IEX.TO) Submits Petition Against Protiva Biotherapeutics 2/26/2007 12:10:58 PM
Protiva Biotherapeutics Drops California Litigation Against INEX Pharmaceuticals (IEX.TO) 12/29/2006 11:23:31 AM